BioCentury | Dec 6, 2004
Company News

Guilford, ProQuest Pharmaceuticals deal

...is in Phase III testing in patients undergoing colonoscopy. Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. ProQuest Pharmaceuticals Inc....
BioCentury | Nov 4, 2002
Company News

ProQuest Pharmaceuticals, Ricerca deal

...biology, chemistry and regulatory support. The companies will share royalties and revenues from resulting products. ProQuest Pharmaceuticals Inc....
BioCentury | Oct 1, 2001
Company News

ProQuest Pharmaceuticals, Inc. other research news

...research the bioavailability and bioconversion of 4 oral cyclic RGD peptidomimetics, which have antithrombotic activity. ProQuest Pharmaceuticals...
BioCentury | Jun 4, 2001
Company News

ProQuest Pharmaceuticals management update

ProQuest Pharmaceuticals Inc. , Lawrence, Kan. Business: Neurological Transition: Osborne Wong to full-time from part-time president WIR Staff Neurology...
BioCentury | May 29, 2001
Company News

ProQuest Pharmaceuticals board of directors update

ProQuest Pharmaceuticals Inc., Lawrence, Kan. Business: Neurological Appointed: Thomas King, former president and CEO of Anesta Corp. ; Jeffrey Jonas, former president and CEO of Avax Technologies Inc. ; and Walter Lovenberg, president of Lovenberg...
BioCentury | May 29, 2001
Company News

ProQuest names president

...Prodrug-based drug delivery company ProQuest Pharmaceuticals (Lawrence, Kansas) hired Osborne Wong as full-time president. He previously served...
BioCentury | Dec 18, 2000
Clinical News

GPI-15715 (PQ-1002): Began Phase I trial

...The trial is expected to begin in the first quarter. GLFD acquired the compound from ProQuest Pharmaceuticals Inc....
BioCentury | Mar 6, 2000
Company News

Guilford, ProQuest Pharmaceuticals deal

...cash. ProQuest is eligible to receive milestones and royalties. Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. ProQuest Pharmaceuticals Inc....
Items per page:
1 - 8 of 8
BioCentury | Dec 6, 2004
Company News

Guilford, ProQuest Pharmaceuticals deal

...is in Phase III testing in patients undergoing colonoscopy. Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. ProQuest Pharmaceuticals Inc....
BioCentury | Nov 4, 2002
Company News

ProQuest Pharmaceuticals, Ricerca deal

...biology, chemistry and regulatory support. The companies will share royalties and revenues from resulting products. ProQuest Pharmaceuticals Inc....
BioCentury | Oct 1, 2001
Company News

ProQuest Pharmaceuticals, Inc. other research news

...research the bioavailability and bioconversion of 4 oral cyclic RGD peptidomimetics, which have antithrombotic activity. ProQuest Pharmaceuticals...
BioCentury | Jun 4, 2001
Company News

ProQuest Pharmaceuticals management update

ProQuest Pharmaceuticals Inc. , Lawrence, Kan. Business: Neurological Transition: Osborne Wong to full-time from part-time president WIR Staff Neurology...
BioCentury | May 29, 2001
Company News

ProQuest Pharmaceuticals board of directors update

ProQuest Pharmaceuticals Inc., Lawrence, Kan. Business: Neurological Appointed: Thomas King, former president and CEO of Anesta Corp. ; Jeffrey Jonas, former president and CEO of Avax Technologies Inc. ; and Walter Lovenberg, president of Lovenberg...
BioCentury | May 29, 2001
Company News

ProQuest names president

...Prodrug-based drug delivery company ProQuest Pharmaceuticals (Lawrence, Kansas) hired Osborne Wong as full-time president. He previously served...
BioCentury | Dec 18, 2000
Clinical News

GPI-15715 (PQ-1002): Began Phase I trial

...The trial is expected to begin in the first quarter. GLFD acquired the compound from ProQuest Pharmaceuticals Inc....
BioCentury | Mar 6, 2000
Company News

Guilford, ProQuest Pharmaceuticals deal

...cash. ProQuest is eligible to receive milestones and royalties. Guilford Pharmaceuticals Inc. (GLFD), Baltimore, Md. ProQuest Pharmaceuticals Inc....
Items per page:
1 - 8 of 8